
Ogibiotec
Automated, modular systems for microbial culturing, enabling faster, more sustainable, and reliable lab-scale microbial growth.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor | €0.0 | round |
investor | €0.0 | round | |
investor investor investor investor investor investor | €0.0 | round | |
* | £650k Valuation: £5.0m | Seed | |
Total Funding | 000k |
Related Content
OGI Bio is a startup that operates in the biotechnology and genetic engineering industry, providing automation solutions for microbial culturing. The company's primary offering is a modular culturing system that replicates manual flask-culturing. This system is designed to be both affordable and flexible, allowing clients to adapt it to their specific culturing needs.
The company's target market includes both industrial and academic microbiology labs. OGI Bio's business model is centered around making automation affordable and accessible. By removing time-intensive repetitive tasks from microbial culturing, the company enables its clients to focus more on innovation and development.
In addition to automation, OGI Bio also provides relevant analytics directly from the cultures. This feature allows for an increase in throughput and a reduction in pipeline, ultimately improving overall process yield. According to the company, a 1% improvement in process yield could lead to as much as $2.8M in additional revenue per batch.
OGI Bio generates revenue by selling its modular culturing system and providing ongoing support and analytics services. The company's commitment to customer success and its innovative approach to automation and analytics position it well for growth in the expanding biotechnology market.
Keywords: Biotechnology, Genetic Engineering, Microbial Culturing, Automation, Analytics, Industrial Microbiology, Academic Microbiology, Modular Culturing System, Process Yield, Affordable Automation.